Literature DB >> 32231700

Prevalence and Clinical Characteristics of Alopecia Areata at a Tertiary Care Center in Saudi Arabia.

Aysha A Alshahrani1,2, Rawan Al-Tuwaijri1,3, Zainah A Abuoliat1,3, Mesnad Alyabsi4, Mohammed I AlJasser1,3,4, Rayan Alkhodair1,3,4.   

Abstract

RESULTS: A total of 216 patients with AA were included. The overall prevalence of AA was approximately 2.3%. The mean disease duration at the time of presentation was 2 months while the mean age of onset was 25.61 years. The most common type of AA in both adult and pediatric groups was the patchy type involving the scalp. Comorbid diseases were found in 32.41% of patients. Common associated conditions included hypothyroidism, diabetes mellitus, and atopic diseases.
CONCLUSION: The overall prevalence of AA among a population of Saudi patients is 2.3%. AA prevalence is higher in pediatrics than adults. Common comorbid conditions include hypothyroidism, diabetes mellitus, and atopic diseases.
Copyright © 2020 Aysha A. Alshahrani et al.

Entities:  

Year:  2020        PMID: 32231700      PMCID: PMC7093899          DOI: 10.1155/2020/7194270

Source DB:  PubMed          Journal:  Dermatol Res Pract        ISSN: 1687-6113


  21 in total

1.  Alopecia in the United States: outpatient utilization and common prescribing patterns.

Authors:  Amy J McMichael; Daniel J Pearce; Dan Wasserman; Fabian T Camacho; Alan B Fleischer; Steven R Feldman; Rajesh Balkrishnan
Journal:  J Am Acad Dermatol       Date:  2007-08       Impact factor: 11.527

2.  A new classification of alopecia areata.

Authors:  T Ikeda
Journal:  Dermatologica       Date:  1965

3.  Prevalence of dermatological disorders in Japan: a nationwide, cross-sectional, seasonal, multicenter, hospital-based study.

Authors:  Masutaka Furue; Souji Yamazaki; Koichi Jimbow; Tetsuya Tsuchida; Masayuki Amagai; Toshihiro Tanaka; Kayoko Matsunaga; Masahiko Muto; Eishin Morita; Masashi Akiyama; Yoshinao Soma; Tadashi Terui; Motomu Manabe
Journal:  J Dermatol       Date:  2011-04       Impact factor: 4.005

4.  A case series of alopecia areata in children: impact of personal and family history of stress and autoimmunity.

Authors:  T Kakourou; K Karachristou; G Chrousos
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-03       Impact factor: 6.166

Review 5.  Overview of alopecia areata.

Authors:  Maria K Hordinsky
Journal:  J Investig Dermatol Symp Proc       Date:  2013-12

6.  Profile of alopecia areata in Northern India.

Authors:  V K Sharma; G Dawn; B Kumar
Journal:  Int J Dermatol       Date:  1996-01       Impact factor: 2.736

7.  Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009.

Authors:  Sultan A Mirzoyev; Adam G Schrum; Mark D P Davis; Rochelle R Torgerson
Journal:  J Invest Dermatol       Date:  2013-11-11       Impact factor: 8.551

8.  Molecular signatures define alopecia areata subtypes and transcriptional biomarkers.

Authors:  Ali Jabbari; Jane E Cerise; James C Chen; Julian Mackay-Wiggan; Madeleine Duvic; Vera Price; Maria Hordinsky; David Norris; Raphael Clynes; Angela M Christiano
Journal:  EBioMedicine       Date:  2016-03-31       Impact factor: 8.143

9.  Alopecia areata and autoimmunity: a clinical study.

Authors:  Emy Abi Thomas; R S Kadyan
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

Review 10.  Alopecia Areata: Review of Epidemiology, Clinical Features, Pathogenesis, and New Treatment Options.

Authors:  Evan Darwin; Penelope A Hirt; Raymond Fertig; Brett Doliner; Gina Delcanto; Joaquin J Jimenez
Journal:  Int J Trichology       Date:  2018 Mar-Apr
View more
  7 in total

Review 1.  Evaluating the Role of lncRNAs in the Incidence of Cardiovascular Diseases in Androgenetic Alopecia Patients.

Authors:  Masoumeh Roohaninasab; Shadnaz Fakhteh Yavari; Motahareh Babazadeh; Rozita Adldoosti Hagh; Mahboubeh Pazoki; Mehran Amrovani
Journal:  Cardiovasc Toxicol       Date:  2022-05-04       Impact factor: 3.231

2.  Clinico-Epidemiological Profile of Childhood Alopecia Areata Along with Dermoscopic Correlation: A Cross-Section, Observational Study.

Authors:  Pallawi Bhardwaj; Dibyendu Basu; Indrashis Podder; Ramesh C Gharami
Journal:  Indian Dermatol Online J       Date:  2021-03-02

3.  Classification Framework for Healthy Hairs and Alopecia Areata: A Machine Learning (ML) Approach.

Authors:  Choudhary Sobhan Shakeel; Saad Jawaid Khan; Beenish Chaudhry; Syeda Fatima Aijaz; Umer Hassan
Journal:  Comput Math Methods Med       Date:  2021-08-14       Impact factor: 2.238

4.  Recovery of Alopecia Universalis with Associated Nail Dystrophy Treated with Tofacitinib: A 6-year-old Child's Case Report.

Authors:  Vineet Dube
Journal:  Int J Trichology       Date:  2021-11-22

5.  Prevalence of alopecia and its contributing factors among primary healthcare attendees in the Jazan region, Saudi Arabia.

Authors:  Abeer R Alomaish; Ibrahim M Gosadi; Fatimah H Dallak; Amjad A Durayb; Ali H Dallak; Jubran A Hakami; Ayman M Hakami; Arar E Alshamakhy; Nouf T Mleeh
Journal:  J Family Med Prim Care       Date:  2021-11-05

6.  CD4, CD8 and natural killer cells are depressed in patients with alopecia areata: their association with disease activity.

Authors:  Abdel-Khalek Younes; Refaat Hammad; Mona Othman; Ali Sobhy
Journal:  BMC Immunol       Date:  2022-03-17       Impact factor: 3.615

7.  Association Between Vitamin D and Zinc Levels With Alopecia Areata Phenotypes at a Tertiary Care Center.

Authors:  Saeed M Alamoudi; Siham M Marghalani; Rakan S Alajmi; Yara E Aljefri; Abdullah F Alafif
Journal:  Cureus       Date:  2021-04-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.